Bio-Solutions Corp. (BISU) to Expand into the DME (Durable Medical Equipment) Sector

Jun. 16, 2011 10:41 AM ETBISU
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Contributor Since 2008

QualityStocks ( assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. The content we provide via Seeking Alpha may be part of our efforts to widen a client’s exposure. To read our full disclaimer, visit

Yesterday, Bio-Solutions Corp. announced that after careful consideration and multiple inquiries from a few American private companies the Company will be expanding their business into the DME (Durable Medical Equipment) sector. The DME Industry is an expanding, yet fragmented, $26 Billion plus a year industry.

Many organically built “Mom and Pop” operations have approached Bio-Solutions Corp. The Company’s Board and Management have decided this would be a beneficial direction to grow and expand the Company.

Dr. Gilles Chaumillon, Chief Executive Officer and President of Bio-Solutions Corp., stated, “This would be a good move both in terms of revenue potential and to build Shareholder Value. I have been very impressed to see what some of these “Mom and Pop”, companies have been capable of.”

“After speaking with many DME industry veterans, we at Bio, see a vast opportunity with Round 2 of Medicare DMEPOS, competitive bidding being initiated before 2013. Recent changes will dictate that DME Companies must transition away from the traditional “Fee Schedule” and enter Competitive Bidding. In return this will take a lot of the pricing burden away from the Taxpayer and Medicare. As a company, our goal is to align ourselves with those in the Competitive Bidding process, as well as those working with various Medicare reimbursement programs. The products lines are endless,” stated Gilles Chaumillon.

Headquartered in Montreal, Quebec, Bio-Solutions Corp. is an NV Corp., traded on the American Markets. Gilles Chaumillon stated, “We play by American rules. Nothing would make me happier, than to grow our business, at the same time trying to put Americans back to work, is that not, what it’s all about?”

For more information visit:

Please see disclaimer on the QualityStocks website:

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.